Clinical Trials on Temporal Hollowing in Argentina

Total 6 results

Hospital Italiano de Buenos Aires

Completed

Drug Interactions and Hip Fracture Risk in Older Adults

Hip Fractures

Argentina
Hospital Italiano de Buenos Aires

Recruiting

Institutional Registry of Hip Fracture in the Elderly

Hip Fracture

Argentina
AO Clinical Investigation and Publishing Documentation

Completed

Latin America Hip Fracture Mortality Study (LAMOS)

Hip Fractures

Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, Mexico, Uruguay
Novartis Pharmaceuticals

Recruiting

A Multi-center Study to Evaluate the Safety, Tolerability and Efficacy of TIN816 in Patients at Risk for Acute Kidney Injury Following Cardiac Surgery.

Acute Kidney Injury Following Cardiac Surgery

France, Taiwan, Belgium, Germany, Argentina, Spain, Czechia, Hungary, Singapore, Lithuania, Estonia, Brazil
Sanofi

Completed

Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture Surgery (SAVE-HIP2)

Venous Thromboembolism

United States, Canada, Poland, Romania, Russian Federation, Ukraine, Italy, Portugal, Spain, Sweden, Turkey, Bulgaria, India, Czech Republic, Mexico, Argentina, Denmark, Finland, Peru, Chile, Belarus, China, South Africa, Greece, Colombia
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of Bimagrumab in Patients After Hip Fracture Surgery

Muscle Wasting (Atrophy) After Hip Fracture Surgery

Colombia, Belgium, Hungary, Taiwan, Spain, Czechia, United States, France, Germany, Turkey, Japan, Russian Federation, United Kingdom, Argentina, Australia, Mexico, Chile, Switzerland, Austria

Clinical Trials on Temporal Hollowing in Argentina

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations